A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

On Christmas Day, Elon Musk turned heads with a decadent photo by his tree. Dressed head-to-toe in a Santa costume, he ...

Exercise includes cardio and strength training, which together support heart health, healthy blood sugar levels, and weight ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

Ozempic has FDA approval to treat type 2 diabetes. Wegovy has approval to help people lose weight when they have both obesity and weight-related health problems. Ozempic and Wegovy are part of a ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...